Octreotide in Intestinal Lymphangiectasia: Lack of a Clinical Response and Failure to Alter Lymphatic Function in a Guinea Pig Model
Intestinal lymphangiectasia, which can be classified as primary or secondary, is an unusual cause of protein-losing enteropathy. The main clinical features include edema, fat malabsorption, lymphopenia and hypoalbuminemia. Clinical management generally includes a low-fat diet and supplementation wit...
Saved in:
Main Authors: | S Makhija, P-Y vod der Weid, J Meddings, SJ Urbanski, PL Beck |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/176568 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal Cryptococcosis Associated with Intestinal Lymphangiectasia
by: Fernando Naranjo-Saltos, et al.
Published: (2020-01-01) -
Elderly Onset Primary Intestinal Lymphangiectasia—A Rare Case
by: Li‐Han Goh, et al.
Published: (2025-01-01) -
Congenital Portal Vein Aneurysm Associated with Peliosis Hepatis and Intestinal Lymphangiectasia
by: Zeynel Mungan, et al.
Published: (2009-01-01) -
Octreotide Treatment of Massive Hemorrhage due to Cytomegalovirus Colitis
by: Christopher N Andrews, et al.
Published: (2003-01-01) -
A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome
by: O. A. Lobanova, et al.
Published: (2023-11-01)